Detalhe da pesquisa
1.
Cardiac complete response in AL amyloidosis has similar survival to matched general population.
Blood
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820591
2.
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.
Blood
; 142(14): 1208-1218, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366170
3.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Lancet Oncol
; 25(5): e205-e216, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697166
4.
Mining the amyloid-plaque proteome to uncover disease mechanisms in renal amyloidoses.
Kidney Int
; 105(3): 427-429, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388139
5.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
N Engl J Med
; 385(1): 46-58, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192431
6.
How I treat AL amyloidosis.
Blood
; 139(19): 2918-2930, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34517412
7.
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival.
Blood
; 140(18): 1964-1971, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772003
8.
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.
Hematol Oncol
; 42(4): e3289, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38824453
9.
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 24(7): e293-e311, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414019
10.
Amyloidogenic light chains impair plasma cell survival.
Haematologica
; 108(12): 3359-3371, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381778
11.
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice.
Am J Hematol
; 98(5): 720-729, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708469
12.
Management of AL amyloidosis in 2020.
Blood
; 136(23): 2620-2627, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270858
13.
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis.
Blood
; 135(18): 1531-1540, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108228
14.
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA.
Blood
; 136(1): 71-80, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32244252
15.
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
Am J Hematol
; 97(6): 719-730, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293006
16.
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients.
Clin Chem Lab Med
; 60(3): 386-393, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018751
17.
Stabilization of amyloidogenic immunoglobulin light chains by small molecules.
Proc Natl Acad Sci U S A
; 116(17): 8360-8369, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971495
18.
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
Eur Heart J
; 42(16): 1554-1568, 2021 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825853
19.
Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.
Int J Mol Sci
; 23(24)2022 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555787
20.
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.
J Biol Chem
; 295(49): 16572-16584, 2020 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32952127